HPi2 anticorps

N° du produit ABIN1722213

Détail du produit anti-HPi2 anticorps

Antigène: HPi2 (HPI2) (Hepatic PMN Infiltration 2 (HPI2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Application: Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro)), Flow Cytometry (FACS), Immunofluorescence (IF)

Specificité: Reacts with human HPi2 protein (specific for multiple endocrine cell types)

Purification: Cell culture supernatant

Immunogène: Human pancreatic enriched islet cells containing low levels of exocrine and ductal cells.

Clone: HIC1-2B4-2B

Isotype: IgG1

Information d'application

Indications d'application:

Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- FC : 1/50 to 1/100 - IHC - F : 1/100

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: DMEM, 10 % FBS + supplements., Sodium azide 0.09 %

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Store at 4°C. Do not freeze.

Détails sur HPi2

Antigène: HPi2 (HPI2) (Hepatic PMN Infiltration 2 (HPI2))

Autre désignation: HPi2

Sujet: Stem cells offer a therapeutic promise for many diseases. In the case of diabetes, stem cells offer the promise that beta cells may be generated ex vivo for the possible transplantation and cure of Type I diabetes (Couri CE, et al.). For this to happen, stem cells will need to be isolated and expanded, they will need to be differentiated toward the beta cell lineage, and the differentiated cell progeny used for transplantation may need to be isolated from complex cell mixtures following differentiation. Appropriate markers targeting cell surface molecules on developing and mature pancreatic cells will be required for such research.